{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:27Z","timestamp":1791549987437,"version":"4.3.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":2363,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,13]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The Fc receptor I for IgA (Fc\u03b1RI) down-regulates humoral immune responses and modulates the risk of autoimmunity. This study aimed to investigate whether Fc\u03b1RI targeting can affect progression of pristine-induced lupus nephritis. In the first experiment (early intervention), four groups of animals were evaluated: untreated Fc\u03b1RI\/FcR\u03b3 transgenic (Tg) mice and Tg mice administered control antibody (Ctr Fab), saline and anti-Fc\u03b1RI Fab [macrophage inflammatory protein (MIP)-8a], respectively, three times a week for 29 weeks, after being injected once intraperitoneally with 0\u00b75\u00a0ml pristane. In the second experiment, antibody injection started after the onset of nephritis and was carried out for 2 months, with similar groups as described above. MIP-8a improved proteinuria, decreased the amounts of glomerular injury markers, serum interleukin (IL)-6, IL-1 and monocyte chemoattractant protein (MCP)-1, and F4\/80 macrophages in the interstitium and glomeruli, in both experiments. When MIP-8a was used as early intervention, a decrease in mouse serum anti-nuclear antibody (ANA) titres and reduced deposition of immunoglobulins in glomeruli were observed. This effect was associated with reduced serum titres of immunoglobulin (Ig)G2a but not IgG1, IgG2b and IgG3. Furthermore, pathological analysis showed lower glomerular activity index and less fibronectin in MIP-8a treated mice. This study suggests that Fc\u03b1RI targeting could halt disease progression and lupus activation by selective inhibition of cytokine production, leucocyte recruitment and renal inflammation. Our findings provide a basis for the use of Fc\u03b1RI as a molecular target for the treatment of lupus.<\/jats:p>","DOI":"10.1111\/cei.12647","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T05:29:38Z","timestamp":1429766978000},"page":"407-416","source":"Crossref","is-referenced-by-count":21,"title":["Targeted IgA Fc receptor I (Fc\u03b1RI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice"],"prefix":"10.1093","volume":"181","author":[{"given":"C","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"},{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kanamaru","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tada","sequence":"additional","affiliation":[{"name":"Research Institute for Diseases of Old Age, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Liu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Tomino","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,2]]},"reference":[{"key":"2021122010154672100_cei12647-bib-0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.134.3.169","article-title":"Systemic lupus erythematosus: prototype of immune complex nephritis in man","volume":"134","author":"Koffler","year":"1971","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"2021122010154672100_cei12647-bib-0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2021122010154672100_cei12647-bib-0004","first-page":"31","article-title":"Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM","volume":"22","author":"Pasquier","year":"2005","journal-title":"Immunity"},{"key":"2021122010154672100_cei12647-bib-0005","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4049\/jimmunol.180.4.2669","article-title":"Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation","volume":"180","author":"Kanamaru","year":"2008","journal-title":"J Immunol"},{"key":"2021122010154672100_cei12647-bib-0006","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1046\/j.1471-4159.2000.0742021.x","article-title":"Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways","volume":"74","author":"Bartoe","year":"2000","journal-title":"J Neurochem"},{"key":"2021122010154672100_cei12647-bib-0007","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/eji.200636826","article-title":"Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor","volume":"37","author":"Kanamaru","year":"2007","journal-title":"Eur J Immunol"},{"key":"2021122010154672100_cei12647-bib-0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood-2006-06-025882","article-title":"IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth","volume":"109","author":"Kanamaru","year":"2007","journal-title":"Blood"},{"key":"2021122010154672100_cei12647-bib-0009","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.191.5.899","article-title":"Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease","volume":"191","author":"Nakamura","year":"2000","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis","volume":"13","author":"Bolland","year":"2000","journal-title":"Immunity"},{"key":"2021122010154672100_cei12647-bib-0011","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20020165","article-title":"Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-\/-) mice","volume":"195","author":"Bolland","year":"2002","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2011.04452.x","article-title":"Negative regulation of inflammatory responses by immunoglobulin A receptor (FcalphaRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis","volume":"166","author":"Watanabe","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2021122010154672100_cei12647-bib-0013","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","article-title":"Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane","volume":"180","author":"Satoh","year":"1994","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0014","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","article-title":"Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane","volume":"92","author":"Satoh","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122010154672100_cei12647-bib-0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol"},{"key":"2021122010154672100_cei12647-bib-0016","first-page":"109","article-title":"Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus","volume":"74","author":"Koffler","year":"1974","journal-title":"Am J Pathol"},{"key":"2021122010154672100_cei12647-bib-0017","first-page":"57","article-title":"Cytokines in the pathogenesis of systemic lupus erythematosus","volume":"19","author":"Kelley","year":"1999","journal-title":"Semin Nephrol"},{"key":"2021122010154672100_cei12647-bib-0018","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/art.20507","article-title":"Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology","volume":"50","author":"Patten","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021122010154672100_cei12647-bib-0019","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI117373","article-title":"Interleukin 6 promotes murine lupus in NZB\/NZW F1 mice","volume":"94","author":"Finck","year":"1994","journal-title":"J Clin Invest"},{"key":"2021122010154672100_cei12647-bib-0020","first-page":"689","article-title":"Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB\/c mice","volume":"151","author":"Lattanzio","year":"1997","journal-title":"Am J Pathol"},{"key":"2021122010154672100_cei12647-bib-0021","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.188.5.985","article-title":"Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus","volume":"188","author":"Richards","year":"1998","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0022","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.23023","article-title":"Deficiency of the type I interferon receptor protects mice from experimental lupus","volume":"56","author":"Nacionales","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122010154672100_cei12647-bib-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8411(03)00083-0","article-title":"Induction of lupus autoantibodies by adjuvants","volume":"21","author":"Satoh","year":"2003","journal-title":"J Autoimmun"},{"key":"2021122010154672100_cei12647-bib-0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2443.2001.00448.x","article-title":"Cross talk of the interferon-alpha\/beta signalling complex with gp130 for effective interleukin-6 signalling","volume":"6","author":"Mitani","year":"2001","journal-title":"Genes Cells"},{"key":"2021122010154672100_cei12647-bib-0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contribution of renal histologic data","volume":"75","author":"Austin","year":"1983","journal-title":"Am J Med"},{"key":"2021122010154672100_cei12647-bib-0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000179336","article-title":"The reproducibility of semiquantitative analyses of renal histology","volume":"1","author":"Pirani","year":"1964","journal-title":"Nephron"},{"key":"2021122010154672100_cei12647-bib-0027","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaut.2010.05.004","article-title":"TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy","volume":"35","author":"Summers","year":"2010","journal-title":"J Autoimmun"},{"key":"2021122010154672100_cei12647-bib-0028","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.186.9.1451","article-title":"Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis","volume":"186","author":"Seery","year":"1997","journal-title":"J Exp Med"},{"key":"2021122010154672100_cei12647-bib-0029","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1201128","article-title":"FcalphaRI-mediated inhibition of IL-12 production and priming by IFN-gamma of human monocytes and dendritic cells","volume":"190","author":"Lecocq","year":"2013","journal-title":"J Immunol"},{"key":"2021122010154672100_cei12647-bib-0030","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.1101763","article-title":"Blocking Fcalpha receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J Immunol"},{"key":"2021122010154672100_cei12647-bib-0031","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2021122010154672100_cei12647-bib-0032","doi-asserted-by":"crossref","first-page":"e10559","DOI":"10.1371\/journal.pone.0010559","article-title":"Genetic risk factors in lupus nephritis and IgA nephropathy \u2013 no support of an overlap","volume":"5","author":"Vuong","year":"2010","journal-title":"PLOS ONE"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12647","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.12647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.12647","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/181\/3\/407\/41791578\/cei12647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/181\/3\/407\/41791578\/cei12647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:28:10Z","timestamp":1641054490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/181\/3\/407\/6422088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,2]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,7,2]]},"published-print":{"date-parts":[[2015,8,13]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12647","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,7,2]]}}}